Beta Bionics, Inc. 10-Q filing
Filed 2026-07-29 · Report date 2026-06-30 · 2026
Filing metadata
- Accession number
- 0001193125-26-323777
- Form type
- 10-Q
- CIK
- 0001674632
- Primary document
- https://www.sec.gov/Archives/edgar/data/1674632/000119312526323777/bbnx-20260630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Beta Bionics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $59.6M | - | - |
| Cost Of Revenue | $24.3M | - | - |
| Gross Profit | $35.3M | - | - |
| Operating Income | $-49.8M | - | - |
| Net Income | $-45.3M | - | - |
| Eps Basic | -1.02 | - | - |
| Eps Diluted | -1.02 | - | - |
| Cash And Equivalents | $44.3M | - | - |
| Total Assets | $292.4M | - | - |
| Total Liabilities | $36.0M | - | - |
| Shareholders Equity | $256.4M | - | - |
| Operating Cash Flow | $-38.5M | - | - |
| Capital Expenditures | $2.4M | - | - |